HighTower Advisors, LLC - CASI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$11,000
+10.0%
13,574
+0.1%
0.00%
Q4 2021$10,000
-16.7%
13,565
+35.4%
0.00%
Q3 2021$12,00010,0210.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,136,00025.80%
Consonance Capital Management LP 10,540,715$25,298,0002.70%
Wellington Shields & Co., LLC 1,832,769$4,399,0001.58%
Tri Locum Partners LP 1,500,000$3,600,0000.89%
Wellington Shields Capital Management, LLC 2,231,765$5,356,0000.51%
Ghost Tree Capital, LLC 650,000$1,560,0000.37%
1492 Capital Management LLC 159,486$382,0000.11%
Ikarian Capital, LLC 1,268,154$3,044,0000.10%
Sio Capital Management, LLC 203,432$488,0000.10%
Aristides Capital LLC 63,250$152,0000.06%
View complete list of CASI PHARMACEUTICALS INC shareholders